Comments
Loading...

Portage Biotech

PRTGNASDAQ
Logo brought to you by Benzinga Data
$7.86
-1.18-13.05%
Pre-Market: 7:59 PM EDT
Portage Biotech (PRTG) announced it will sell assets to Immunova, LLC on Tuesday, December 17, 2024

Portage Biotech (NASDAQ:PRTG) Stock, Earnings Estimates, EPS, And Revenue

Portage Biotech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 26
EPS
$-1.260
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)

Analyze the earnings history of Portage Biotech using advanced sorting and filters.

Data brought to you by Benzinga APIs

Portage Biotech (PRTG) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Dec 20232024-02-28$-37.60$-5.40-596.3 %
Sep 20232023-11-28$-5.80$-5.60-3.57 %
Jun 20232023-08-30$-6.60$-4.80-37.5 %
Jun 20232023-07-31$-8.00$-5.40-48.1 %

Portage Biotech (PRTG) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is Portage Biotech (NASDAQ:PRTG) reporting earnings?

A

Portage Biotech (PRTG) is scheduled to report earnings on February 26, 2025. The last reported earnings were for reported on November 26, 2024 for Q2.

Q

What were the latest earnings per share (EPS) for Portage Biotech (NASDAQ:PRTG)?

A

The Actual EPS was $-1.26, which missed the estimate of $0.00.

Q

What were Portage Biotech’s (NASDAQ:PRTG) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch